Equities

Target Group Inc

CBDY:PKC

Target Group Inc

Actions
  • Price (USD)0.0059
  • Today's Change0.00 / 0.00%
  • Shares traded1.78k
  • 1 Year change+78.79%
  • Beta0.4752
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Target Group Inc. is a cannabis and hemp consumer packaged goods (CPG) company. The Company is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada and in the United States. Its products include Cannabis flower pods for vaporizer use, Cannabis extract pods for vaporizer use, Cannabis pre-rolls, K-Cup infused coffee and tea pots, Infused cannabis beverages, Infused cannabis edibles and infused topical products and CBD wellness products. The Company's subsidiary, Canary Rx Inc, is a Canadian licensed producer, which operates an approximately 44,000 square foot facility located in Norfolk County, Ontario. The Company's subsidiary, CannaKorp Inc., has developed a single-use pre-measured pod and vaporizer system, such as The Wisp and Wisp Pods for consumers interested in vaporizing natural herbs, including cannabis.

  • Revenue in USD (TTM)5.64m
  • Net income in USD228.87k
  • Incorporated2013
  • Employees46.00
  • Location
    Target Group Inc55 Administration Rd Unit 13VAUGHAN L4K-4G9CanadaCAN
  • Phone+1 (905) 541-3833
  • Fax+1 (416) 441-4632
  • Websitehttps://www.targetgroupinc.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cannapharmarx Inc0.00-7.50m3.38m6.00---------0.0274-0.02740.00-0.07150.00----0.00-141.75-161.34---------------3.49--------3.41------
Cyclacel Pharmaceuticals Inc420.00k-22.76m3.42m12.00--4.08--8.15-26.72-26.720.49240.57320.0228--0.1106---122.40-57.58-212.95-69.81-----5,370.24-18,789.29---170.830.00----22.87-6.34---31.23--
GB Sciences Inc0.00-4.03m3.45m3.00---------0.0105-0.01050.00-0.01190.00----0.00-255.86-49.16---131.40--6.03---995.19---8.63---------2,715.25---60.82--
Altamira Therapeutics Ltd0.00-8.02m3.49m10.00--0.3234-----16.33-8.690.004.820.0034.0532.300.00-103.88-73.80-6,364.67-123.19-87.90------1.38-4.370.0152------61.02------
Atreca Inc0.00-97.76m3.57m90.00--0.3318-----2.49-2.490.000.27150.00----0.00-98.54-44.99-116.19-48.05------------0.00------11.13---8.46--
Scorpius Holdings Inc2.23m-46.05m3.61m77.00--0.0719--1.62-1.78-2.000.08591.390.0234--0.676228,918.57-50.05-38.42-61.25-42.0629.10---2,136.28-703.02----0.2305--202.1233.24-23.85--218.50--
Target Group Inc5.64m228.87k3.64m46.0045.38--3.420.64550.00010.00010.0088-0.01150.7648.60124.27115,104.103.10-37.99---78.7643.71--4.06-586.970.07360.01493.10----577.8392.84---58.54--
Theralink Technologies Inc635.46k-13.50m3.69m16.00------5.81-0.0027-0.00270.00006-0.00930.2525--13.5139,716.25-536.39------73.50---2,124.10-----1.35----6.85---138.38------
Zyversa Therapeutics Inc0.00-106.25m3.69m7.00--0.1778-----1,922.89-1,922.890.0027.330.00----0.00-139.81---160.83--------------0.00-------340.15------
Bon Natural Life Ltd29.52m4.60m3.71m96.000.5330.0880.67320.12564.994.9932.1030.230.704515.275.19307,524.6010.8614.0413.6920.6829.9430.0015.4217.622.4130.540.09550.00-1.2922.32-26.3283.09-6.70--
Mustang Bio Inc0.00-40.10m3.76m80.00---------4.55-4.550.00-0.47570.00----0.00-90.93-70.02-138.05-79.98-----------15.88--------33.44---60.75--
Petros Pharmaceuticals Inc5.82m-13.81m3.84m21.00--0.1358--0.659-6.35-6.352.744.170.17590.95242.69277,256.70-24.66-32.43-33.75-68.0571.9862.04-140.20-201.701.74--0.391---2.83-16.1531.06------
Bio Path Holdings Inc0.00-16.08m3.88m10.00--3.28-----35.76-35.760.000.71360.00----0.00-167.56-70.80-206.12-76.87------------0.00-------15.94------
Sonoma Pharmaceuticals Inc12.31m-5.08m3.90m9.00--0.5112--0.317-0.9608-0.96081.950.4890.86252.584.761,367,778.00-35.56-37.52-47.14-51.3539.1740.17-41.23-37.123.11--0.0065--5.10-4.44-1.28--7.54--
Data as of May 16 2024. Currency figures normalised to Target Group Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.